Claire Acevedo

Claire Acevedo

Auto-generated profile, based on publicly available information

Claire Acevedo

Department of Mechanical and Aerospace Engineering, University of California San Diego, La Jolla, 92093, CA, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Cell Reports
Verified
Journal Article
Open access
NDNeha Dole
Neha Dole
CMCourtney M. Mazur
Courtney M. Mazur
CAClaire Acevedo
Claire Acevedo
JLJustin P. Lopez
Justin P. Lopez
DMDavid A. Monteiro
David A. Monteiro
TATamara Alliston
Tamara Alliston
Poor bone quality contributes to bone fragility in diabetes, aging, and osteogenesis imperfecta. However, the mechanisms controlling bone quality are not well understood, contributing to the current lack of strategies to diagnose or treat bone quality deficits. Transforming growth factor beta (TGF-β) signaling is a crucial mechanism known to regulate the material quality of bone, but its cellular target in this regulation is unknown. Studies showing that osteocytes directly remodel their perilacunar/canalicular matrix led us to hypothesize that TGF-β controls bone quality through perilacunar/canalicular remodeling (PLR). Using inhibitors and mice with an osteocyte-intrinsic defect in TGF-β signaling (TβRIIocy-/-), we show that TGF-β regulates PLR in a cell-intrinsic manner to control bone quality. Altogether, this study emphasizes that osteocytes are key in executing the biological control of bone quality through PLR, thereby highlighting the fundamental role of osteocyte-mediated PLR in bone homeostasis and fragility.

22 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TFTristan W. Fowler
Tristan W. Fowler
CAClaire Acevedo
Claire Acevedo
CMCourtney M. Mazur
Courtney M. Mazur
FHFaith Hall-Glenn
Faith Hall-Glenn
AFAaron Fields
Aaron Fields
TATamara Alliston
Tamara Alliston
Through a process called perilacunar remodeling, bone-embedded osteocytes dynamically resorb and replace the surrounding perilacunar bone matrix to maintain mineral homeostasis. The vital canalicular networks required for osteocyte nourishment and communication, as well as the exquisitely organized bone extracellular matrix, also depend upon perilacunar remodeling. Nonetheless, many questions remain about the regulation of perilacunar remodeling and its role in skeletal disease. Here, we find that suppression of osteocyte-driven perilacunar remodeling, a fundamental cellular mechanism, plays a critical role in the glucocorticoid-induced osteonecrosis. In glucocorticoid-treated mice, we find that glucocorticoids coordinately suppress expression of several proteases required for perilacunar remodeling while causing degeneration of the osteocyte lacunocanalicular network, collagen disorganization, and matrix hypermineralization; all of which are apparent in human osteonecrotic lesions. Thus, osteocyte-mediated perilacunar remodeling maintains bone homeostasis, is dysregulated in skeletal disease, and may represent an attractive therapeutic target for the treatment of osteonecrosis.

16 February 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EZElizabeth A. Zimmermann
Elizabeth A. Zimmermann
ESEric Schaible
Eric Schaible
BGBernd Gludovatz
Bernd Gludovatz
FSFelix N. Schmidt
Felix N. Schmidt
CRChristoph Riedel
Christoph Riedel
BBBjörn Busse
Björn Busse
Bisphosphonates are a common treatment to reduce osteoporotic fractures. This treatment induces osseous structural and compositional changes accompanied by positive effects on osteoblasts and osteocytes. Here, we test the hypothesis that restored osseous cell behavior, which resembles characteristics of younger, healthy cortical bone, leads to improved bone quality. Microarchitecture and mechanical properties of young, treatment-naïve osteoporosis and bisphosphonate-treated cases were investigated in femoral cortices. Tissue strength was measured using three-point bending. Collagen fibril-level deformation was assessed in non-traumatic and traumatic fracture states using synchrotron small-angle x-ray scattering (SAXS) at low and high strain rates. The lower modulus, strength and fibril deformation measured at low strain rates reflects susceptibility for osteoporotic low-energy fragility fractures. Independent of age, disease and treatment status, SAXS revealed reduced fibril plasticity at high strain rates, characteristic of traumatic fracture. The significantly reduced mechanical integrity in osteoporosis may originate from porosity and alterations to the intra/extrafibrillar structure, while the fibril deformation under treatment indicates improved nano-scale characteristics. In conclusion, losses in strength and fibril deformation at low strain rates correlate with the occurrence of fragility fractures in osteoporosis, while improvements in structural and mechanical properties following bisphosphonate treatment may foster resistance to fracture during physiological strain rates.

17 January 2018 in Journal of Bone and Mineral Research
Verified
Journal Article
Closed access
PDF file
CAClaire Acevedo
Claire Acevedo
MSMeghan Sylvia
Meghan Sylvia
ESEric Schaible
Eric Schaible
JGJames Lawrence Graham
James Lawrence Graham
KSKimber L Stanhope
Kimber L Stanhope
AFAaron Fields
Aaron Fields

22 January 2018 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
CAClaire Acevedo
Claire Acevedo
VSVincent A. Stadelmann
Vincent A. Stadelmann
DPDominique P. Pioletti
Dominique P. Pioletti
TATamara Alliston
Tamara Alliston
RRRobert O. Ritchie
Robert O. Ritchie

1 December 2015 in Bone
Verified
Journal Article
Closed access
CAClaire Acevedo
Claire Acevedo
HBHrishikesh Bale
Hrishikesh Bale
BGBernd Gludovatz
Bernd Gludovatz
AWAmy Wat
Amy Wat
STSimon Tang
Simon Tang
RRRobert O. Ritchie
Robert O. Ritchie